Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Luminist Labs
AddedMar 22, 2024
UpdatedJul 1, 2026
Luminist Labs

Luminist Labs

Acquired

Luminist offers a non-invasive test for early liver disease detection.

HQ
Newark, CA, US
Founded
2015
Accelerator
Y Combinator logoY CombinatorW16
Overview
Compare
Fundraising
Employees

Luminist Labs focuses on early detection of liver disease through a non-invasive diagnostic platform. Their primary product is a test designed to identify and stage liver fibrosis and non-alcoholic steatohepatitis (NASH). The company aims to provide accessible and accurate diagnostics to improve patient outcomes.

Luminist Labs was acquired by DiscernDx in 2020, marking a significant milestone in their journey. Their innovative approach to liver disease detection has positioned them as a key player in the diagnostic market, contributing to advancements in non-invasive medical testing.

Luminist Labs - Similar Companies

Luminostics logo

Luminostics

Livivos logo

Livivos

livivos.com

Liquid Biotech logo

Liquid Biotech

Amplified Sciences logo

Amplified Sciences

Lucence logo

Lucence

lucence.com

Empowered Diagnostics logo

Empowered Diagnostics

Unima logo

Unima

i-Lumen Scientific logo

i-Lumen Scientific

i-lumen.com

Phdx logo

Phdx

OmniVis logo

OmniVis

NanoMosaic logo

NanoMosaic

Lucid Diagnostics logo

Lucid Diagnostics

luciddx.com

Durin Technologies logo

Durin Technologies

Glycotest logo

Glycotest

glycotest.com

eLum Technologies logo

eLum Technologies

Luminist Labs - Quick Facts

Who are Luminist Labs' competitors?

Companies similar to Luminist Labs include Luminostics, Livivos, Liquid Biotech and Amplified Sciences.

When was Luminist Labs founded?

Luminist Labs was founded in 2015.

Where is Luminist Labs' headquarters located?

Luminist Labs' headquarters is located in Newark, CA, US.

When was Luminist Labs' last funding round?

Luminist Labs' most recent funding round was for $120k (USD) in March 2016.

How much has Luminist Labs raised to-date?

As of Mar 22, 2016, Luminist Labs has raised a total of $120k (USD).

Luminist Labs - Classification

NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified